deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT02364206

Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma (GLYRad)

Phase I/II Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma

Sponsor: ARC Foundation for Cancer Research

Conditions Adult Glioblastoma
Interventions LY2228820 Temozolomide radiotherapy
Updated 9 times since 2017 Last updated: Aug 13, 2019 Started: Jun 8, 2015 Primary completion: Aug 31, 2019 Completion: Aug 31, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02364206, this PHASE1/PHASE2 trial focuses on Adult Glioblastoma and remains completed. Sponsored by ARC Foundation for Cancer Research, it has been updated 9 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshotRecruiting~Aug 2017 – ~Mar 2018 · 7 months · monthly snapshotRecruiting~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshotActive Not Recruiting~Dec 2018 – ~Sep 2019 · 9 months · monthly snapshotActive Not Recruiting~Sep 2019 – ~Jan 2021 · 16 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  4. Sep 2019 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

    Status: Active Not Recruiting → Completed

  5. Dec 2018 — Sep 2019 [monthly]

    Active Not Recruiting PHASE1_PHASE2

▶ Show 4 earlier versions

  1. Jun 2018 — Dec 2018 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  2. Mar 2018 — Jun 2018 [monthly]

    Active Not Recruiting PHASE1_PHASE2

    Status: Recruiting → Active Not Recruiting

  3. Aug 2017 — Mar 2018 [monthly]

    Recruiting PHASE1_PHASE2

  4. Jan 2017 — Aug 2017 [monthly]

    Recruiting PHASE1_PHASE2

    First recorded

Jun 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • ARC Foundation for Cancer Research
  • Centre Jean Perrin
  • National Cancer Institute, France
Data source: Centre Jean Perrin

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations